Proskauer

Laura Goldsmith is a partner in the Technology, Media and Telecommunications Group and a member of the Life Sciences and Privacy & Cybersecurity Groups.  She advises life sciences, healthcare and other technology-driven businesses and their investors on complex technology, intellectual property and data issues in commercial and corporate transactions, helping clients generate, protect and monetize value across the product and business life cycle. Her experience spans a broad range of industries, including software and digital businesses, fintech, media and entertainment, and the sports and gaming ecosystem.

Laura structures and negotiates sophisticated technology transactions, including licenses, R&D collaborations, joint development and commercialization arrangements, technology-enabled supply chain and services arrangements, and SaaS and other platform agreements. She brings this experience to bear in advising on technology, intellectual property and data issues in mergers and acquisitions, carve-out transactions, strategic investments, private credit transactions and other corporate transactions.

She counsels clients operating at the intersection of technology, data and regulated markets, including sports betting and gaming. In this rapidly evolving space, she represents sports leagues, gaming operators and technology companies in data rights transactions, technology licenses and other commercial partnerships.

Laura helps clients navigate compliance with international, federal and state privacy and data protection laws in the context of transactions, vendor relationships, internal compliance programs and external-facing policies.  She is an editor and contributor to the Proskauer on Privacy blog and a contributor to the State Privacy Laws and Financial Privacy chapters of the Proskauer on Privacy treatise published by PLI.

Laura serves on the Proskauer Women’s Alliance Steering Committee and previously served as its co-chair.

Before practicing law, Laura worked as a consultant to global pharmaceutical companies on drug development strategy and clinical trial design and conducted pharmacology and biology research at Duke University Medical Center, publishing in peer-reviewed journals. During law school at Boston University, she served as Editor-in-Chief of the Review of Banking & Financial Law and interned for Judge Kiyo A. Matsumoto of the U.S. District Court for the Eastern District of New York.